• Hyperbranched Lipopolyplexes for Stable mRNA Delivery

  2026-10-08

  Meng and colleagues describe a ternary lipid/hyperbranched poly-L-lysine/mRNA lipopolyplex designed to reconcile storage stability with intracellular mRNA release. The reported results link the HBPL core to efficient delivery in several experimental settings, while also indicating that the platform’s durability, mechanism, and translational relevance require further validation.

• How HBsAg Reprograms TBK1, Interferon, and Autophagy

  2026-10-07

  A 2025 Cell Death and Disease study identifies a mechanism by which hepatitis B surface antigen redirects TBK1 activity away from IRF3-dependent interferon signaling and toward autophagy-related responses. The findings connect HBsAg–TBK1 binding, incomplete autophagy, and HBV persistence while highlighting important limits in translating cell, mouse, and patient-tissue observations into therapeutic conclusions.

• Sumatriptan and Inflammation: Evidence Beyond Migraine

  2026-10-07

  Ala et al. synthesized evidence that sumatriptan, a 5-HT1 receptor agonist, may influence inflammatory signaling beyond its established role in migraine. Their review connects cytokine regulation, nitric oxide and CGRP pathways, and tissue-protection findings while emphasizing that most evidence remains preclinical and heterogeneous.

• Idoxuridine: From DNA Mechanism to Translation

  2026-10-06

  A translational perspective on Idoxuridine as a nucleoside analog and viral DNA synthesis inhibitor, with strategic guidance for mechanism-first antiviral research and a cautious comparison to human neuropharmacology evidence.

• Rgs16::GFP Screening for PDA Drug Combinations

  2026-10-06

  Layeghi-Ghalehsoukhteh and colleagues developed a connected cell-culture and mouse screening framework using Rgs16::GFP to prioritize treatments for pancreatic ductal adenocarcinoma. The study identified enhanced activity from combining gemcitabine, the HDAC inhibitor TSA, and JQ1, while also showing why biomarker-guided validation remains necessary before extrapolating results to human therapy.

• Idoxuridine: An Evidence-Led Research Framework

  2026-10-05

  Idoxuridine, also known as 5-iodo-2'-deoxyuridine, is examined here as a research tool for studying viral DNA synthesis inhibition. Rather than presenting a protocol, this article connects molecular mechanism, assay interpretation, product provenance, and lessons from human-neuron pharmacology.

• Ceramides Promote RGNNV Replication via Autophagy

  2026-10-05

  A 2026 Journal of Virology study used lipidomics and complementary perturbation evidence to identify ceramide accumulation as a pro-viral feature of red-spotted grouper nervous necrosis virus infection. The findings connect viral capsid protein activity, sphingolipid metabolism, and autophagy, while supporting ceramide flux as a potential host-directed research focus in aquaculture virology.

• TMB Substrate Solution for ELISA: Reading ISR Biology

  2026-10-04

  Learn how a TMB substrate solution for ELISA can support protein-level investigation of the integrated stress response without being mistaken for a direct measure of translation or ribosome biology. This evidence-focused guide connects assay interpretation with findings from a recent XPG-related Cockayne syndrome study.

• ICG001 and Wnt Signaling in Bone Research

  2026-10-03

  ICG001 is a research tool for examining CBP-dependent β-catenin transcription, while recent work links lithium-treated BMSC exosomes and Wnt10a signaling to enhanced osteogenesis. The evidence supports a plausible mechanistic research question, but does not establish ICG001 as a bone-regeneration treatment or validate its effects in the lithium–exosome model.

• Thermoresponsive PEG Shedding Improves mRNA Delivery

  2026-10-02

  The reference study introduces oxanorbornadiene-linked PEG–lipids that shed from lipid nanoparticles at programmable rates, addressing the trade-off between extracellular stability and cellular uptake. Its route-specific experiments show that rapid or intermediate PEG removal can improve pulmonary or systemic mRNA delivery while preserving the transport advantages of PEGylation.

• Affinity-Purified Goat Anti-Mouse IgG (H+L) Workflow

  2026-10-01

  Build sensitive, reproducible Western blot, ELISA, IHC, and ICC workflows with a broad-reactivity HRP secondary antibody. This guide translates mitochondrial calcium research into practical detection strategies, with starting conditions, controls, storage guidance, and troubleshooting for mouse primary antibodies.

• GW4064: Strategic FXR Activation for Translation

  2026-10-01

  GW4064 is a potent non-steroidal FXR agonist that connects bile acid biology, lipid homeostasis, inflammation, and fibrotic signaling. This thought-leadership guide translates recent FXR/TLR4/ferroptosis findings into practical strategies for rigorous metabolic and liver research.

• Dual-Fluorescence mRNA for Translational Delivery

  2026-09-30

  Why dual readouts matter in mRNA delivery: EZ Cap™ Cy5 EGFP mRNA (5-moUTP) connects cellular uptake with functional protein expression, helping researchers distinguish delivery, trafficking, translation, and tolerability during translational development.

• Sisomicin BA1199: Reliable Assay Workflows

  2026-09-30

  Learn how Sisomicin (SKU BA1199) can strengthen in vitro antibacterial testing while helping laboratories interpret cell viability and cytotoxicity results without confusing antimicrobial activity with mammalian-cell effects. This scenario-based guide connects historical MIC data with practical concentration, handling, resistance, and vendor-selection decisions.

• From Uptake to Function: Smarter mRNA Delivery

  2026-09-29

  A translational framework for separating mRNA uptake, intracellular delivery, translation, and cell fitness—using dual-fluorescent reporting to strengthen LNP and serial cell-engineering decisions.

8149 records 1/544 page Next 12345 下5页 Last page